Batch Enrollment for AI-Guided Intervention to Lower Neurologic Events in Unrecognized AF

Overview

About this study

This is a prospective study to test a novel artificial intelligence (AI)-enabled electrocardiogram (ECG)-based screening tool for improving the diagnosis of unrecognized atrial fibrillation (AF) and stroke prevention.

Participation eligibility

Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. There is no guarantee that every individual who qualifies and wants to participate in a trial will be enrolled. Contact the study team to discuss study eligibility and potential participation.

Inclusion Criteria:

  • Adult patients (18 years or older) who have had a 10-second 12-lead ECG at Mayo Clinic and have a CHA2DS2-VASc ≥ 2 for men or CHA2DS2-VASc ≥3 for women.
  • Adult patients who have AI-detected AF and are eligible for anticoagulation will be eligible for the first group of patients.
  • Adult patients who do not have AI-detected AF but are similar to the first group in other aspects will be eligible as part of the second group of patients.

Exclusion Criteria:

  • Patients with diagnosed atrial fibrillation or atrial flutter, on anticoagulation or have another indication for anticoagulation (e.g., mechanical valve), missing DOB or sex in EHR, history of intracranial bleeding, history of end-stage kidney disease, or have an implantable cardiac monitoring device (pacemaker, debfibrillator, implanted loop recorded).
  • Patients who are deemed by research personnel to have limitations that would prevent them from being able to provide informed consent, use the patch, or complete interviews will not be included.

Participating Mayo Clinic locations

Study statuses change often. Please contact the study team for the most up-to-date information regarding possible participation.

Mayo Clinic Location Status Contact

Rochester, Minn.

Mayo Clinic principal investigator

Xiaoxi Yao, Ph.D., M.P.H.

Closed-enrolling by invitation

What is this? (?)
"Close"
Not open to everyone who meets the eligibility criteria, but only those invited to participate by the study team.

Contact information:

Emma Behnken

(507) 293-0177

Behnken.Emma@mayo.edu

More information

Publications

Publications are currently not available

Study Results Summary

Not yet available

Supplemental Study Information

Not yet available

.
CLS-20502721

Mayo Clinic Footer